series-c-plus
Stage
2
Investors
About
Atreca, Inc. is a biotechnology company developing novel oncology therapeutics by leveraging deep insights into the human immune response.
Explore Atreca, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.